TRON Group Inc. (TGRP)
OTCMKTS · Delayed Price · Currency is USD
0.0520
+0.0120 (30.00%)
Apr 7, 2026, 4:00 PM EST
TRON Group Market Cap
TRON Group has a market cap or net worth of $9.57 million as of April 8, 2026. Its market cap has decreased by -94.09% in one year.
Market Cap
9.57M
Enterprise Value
n/a
Revenue
1.01M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.05
Market Cap Chart
Since February 21, 2018, TRON Group's market cap has decreased from 232.00M to 9.57M, a decrease of -95.88%. That is a compound annual growth rate of -32.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 7, 2026 | 9.57M | 15.56% |
| Dec 30, 2025 | 8.28M | -35.34% |
| Dec 30, 2024 | 12.81M | -95.09% |
| Dec 27, 2021 | 261.00M | 71.71% |
| Dec 29, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 13, 2018 | Upgrade Pro | Upgrade Pro |
| Feb 21, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Brainstorm Cell Therapeutics | 9.52M |
| Nymox Pharmaceutical | 8.16M |
| Curative Biotechnology | 7.87M |
| NKGen Biotech | 7.84M |
| BetterLife Pharma | 7.08M |
| Synlogic | 6.96M |
| Bioxytran | 5.47M |
| Mosaic ImmunoEngineering | 5.40M |